Azenta, Inc. (NASDAQ:AZTA)
| Market Cap | $1.87B+22.1% |
| Revenue (ttm) | $621.70M+4.7% |
| Net Income | -$166.99M-212.8% |
| EPS | -$3.62-178.5% |
| Shares Out | 41.76M |
| PE Ratio | n/a |
| Forward PE | 50.34 |
| Dividend | n/a |
| Ex-Dividend Date | Dec 2, 2021 |
| Volume | 621,109 |
| Open | $46.09 |
| Previous Close | $47.09 |
| Day's Range | $44.20 - $46.65 |
| 52-Week Range | $15.93 - $50.06 |
| Beta | 1.47 |
| Analysts | Buy |
| Price Target | $52.00(+16.07%) |
| Earnings Date | Feb 3, 2027 |
About AZTA
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
Analyst consensus
2 firms rating AZTA in the last 3 months, one vote each. Issuer-paid research is not counted.
Next catalysts
- Feb 3, 2027Earnings report
$AZTA stock is featured in our Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of AZTA by members of U.S. Congress
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 3, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 3, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 2, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 15, 2026 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 15, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Jan 14, 2026 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 9, 2025 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Oct 9, 2025 |
Recently reported changes in AZTA holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by AZTA's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
AZTA Estimated quarterly lobbying spending
Source: U.S. Senate LDA
AZTA Revenue by Segment or Geography
| Multiomics | $277.26M | 44.60% |
| Core Products | $191.80M | 30.85% |
| Sample Repository Services | $152.64M | 24.55% |
As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-K)
U.S. Patents
New AZTA patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to AZTA from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in AZTA
| IJRiShares Core S&P Small-Cap ETF | $106.40M |
| IWMiShares Russell 2000 ETF | $50.66M |
| VTIVanguard Morningstar Total Stock Market ETF | $39.50M |
| VBVanguard Morningstar Small-Cap ETF | $34.59M |
| DFSVU.S. Small Cap Value Portfolio ETF Class Shares | $23.56M |
| VBRVanguard Morningstar Small-Cap Value ETF | $22.45M |
Estimated from each fund’s disclosed top holdings × AUM
Bull Case vs Bear Case
AI-generated from AZTA’s recent data — informational, not investment advice
What’s Behind the Score
News check: Strong analyst upgrade and earnings beats drive bullish tone; concrete positive catalysts including revenue guidance outperformance and earnings growth.
Recent Insider Activity
Frequently Asked Questions
ETFs that hold this stock
| SVAL | iShares US Small Cap Value Factor ETF | 0.78% |
| FTKI | First Trust Small Cap BuyWrite Income ETF | 0.24% |
| FTQI | First Trust Nasdaq BuyWrite Income ETF | 0.19% |
| KOMP | State Street SPDR S&P Kensho New Economies Composite ETF | 0.17% |
| SMLV | State Street SPDR US Small Cap Low Volatility Index ETF | 0.17% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.16% |
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 0.14% |
| NUSC | Nuveen ESG Small-Cap ETF | 0.14% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 0.14% |
| IWN | iShares Russell 2000 Value ETF | 0.14% |
| XJR | iShares ESG Select Screened S&P Small-Cap ETF | 0.12% |
| ESML | iShares ESG Aware MSCI USA Small-Cap ETF | 0.12% |
Weight is the stock’s share of each fund’s holdings.
